Top compounds associated with response to LRRTM3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA KU-55933 GDSC1000 pan-cancer AAC -0.052 0.1
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.045 0.1
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.087 0.1
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.055 0.1
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.16 0.1
mRNA A-770041 GDSC1000 pan-cancer AAC -0.074 0.1
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.047 0.1
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.049 0.1
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.1
Download CSV